International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Special Issue 6
Original Research Article
Comparison of Ropivacaine with Dexamethasone and Ropivacaine in Infraclavicular Brachial Plexus Block for Post Operative Analgesia
Published
Dec. 30, 2024
Abstract

Background and Objectives: Dexamethasone has been shown to prolong the duration of analgesia when used as an adjuvant to local anesthetics in peripheral nerve blocks. This study aimed to compare the effects of ropivacaine alone and ropivacaine with dexamethasone on the onset and duration of sensory and motor block, as well as the duration of analgesia, in infraclavicular brachial plexus block for upper extremity surgeries. Methods: In this prospective, randomized study, 40 patients were allocated into two groups: Group R (n=20) received 20 mL of 0.5% ropivacaine with 2 mL normal saline, and Group D (n=20) received 20 mL of 0.5% ropivacaine with 8 mg dexamethasone. The onset and duration of sensory and motor block, duration of analgesia, postoperative pain scores, and rescue analgesic consumption were assessed. Results: The onset of sensory block (11.2 ± 2.9 min vs. 16.5 ± 3.8 min, p<0.001) and motor block (14.6 ± 3.5 min vs. 21.8 ± 4.7 min, p<0.001) was significantly faster in Group D compared to Group R. The duration of sensory block (738.6 ± 96.2 min vs. 512.4 ± 74.9 min, p<0.001), motor block (664.3 ± 88.7 min vs. 462.1 ± 63.5 min, p<0.001), and analgesia (875.2 ± 102.4 min vs. 589.3 ± 81.6 min, p<0.001) was significantly prolonged in Group D. Postoperative pain scores were lower, and rescue analgesic consumption was reduced in Group D (1.3 ± 1.0 vs. 2.4 ± 0.9, p=0.001). The incidence of adverse events was similar between the groups. Conclusion: The addition of dexamethasone to ropivacaine in infraclavicular brachial plexus block significantly enhances the onset and duration of sensory and motor block, as well as the duration of analgesia, compared to ropivacaine alone, without increasing the risk of adverse events.

Recommended Articles
Loading Image...
Volume-5, Special Issue 6
Citations
544 Views
480 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved